Merger14 May 2026, 07:01 pm
Brooks Labs: BSL Scheme of Arrangement Not Pursued
AI Summary
Brooks Laboratories Ltd reports that Brooks Steriscience Limited (BSL), a joint venture/associate, has decided not to pursue the proposed composite scheme of arrangement and amalgamation involving Steriscience Specialties Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited and Onesource Specialty Pharma Limited in its current form. The decision was made by BSL's Board of Directors in the best interest of all stakeholders.
Key Highlights
- Brooks Steriscience Limited (BSL) will not pursue the proposed scheme of arrangement.
- The decision was made by BSL's Board of Directors.
- The original scheme involved multiple entities including Steriscience Specialties and Strides Pharma Services.
- The initial in-principle approval was received from NSE and BSE.
Price Impact
More from BROOKS
More in Merger